Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Antengene, Ascendis, Astellas, Biontech, Cerecor, Cstone, Everest Medicines, Icanomab, Ix, Organicell Regenerative Medicine, Pfizer, RDIF.